Conditions: Targeted Therapy; HER2; Biliary Tract Cancer; Esophageal Squamous Cell Carcinoma
Interventions: Drug: chemotherapy in combination with trastuzumab; Drug: chemotherapy in combination with trastuzumab; Drug: chemotherapy in combination with trastuzumab
Sponsor: Shen Lin
Not yet recruiting - verified June 2017
http://ift.tt/2sqfx27
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Abstract The changes of dissolved organic matter (DOM) components during stabilization process play significant effects on its redox prope...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου